Skip to main content
ADMA BIOLOGICS, INC. logo

ADMA BIOLOGICS, INC. — Investor Relations & Filings

Ticker · ADMA ISIN · US0008991046 US Manufacturing
Filings indexed 960 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country US United States of America
Listing US ADMA

About ADMA BIOLOGICS, INC.

https://www.admabiologics.com/

ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company that develops, manufactures, and commercializes specialty plasma-derived biologics. The company's portfolio features FDA-approved immune globulin (Ig) products for the treatment of immune-compromised patients and individuals at risk for certain infections. ADMA Biologics operates a vertically integrated manufacturing process for its specialty biologic products and utilizes a patented immunotechnology platform, which includes a proprietary microneutralization assay to measure neutralizing antibody levels in plasma. The company also offers contract manufacturing capabilities.

Recent filings

Filing Released Lang Actions
8-K - ADMA BIOLOGICS, INC. (0001368514) (Filer)
Regulatory Filings
2026-05-04 English
ARS - ADMA BIOLOGICS, INC. (0001368514) (Filer)
Annual Report
2026-04-15 English
DEF 14A - ADMA BIOLOGICS, INC. (0001368514) (Filer)
Proxy Solicitation & Information Statement
2026-04-15 English
8-K - ADMA BIOLOGICS, INC. (0001368514) (Filer)
Regulatory Filings
2026-03-27 English
SCHEDULE 13G/A - ADMA BIOLOGICS, INC. (0001368514) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
Director's Dealing
2026-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.